Literature DB >> 29870668

Discovery of Novel Topoisomerase II Inhibitors by Medicinal Chemistry Approaches.

Wei Hu1, Xu-Sheng Huang2, Ji-Feng Wu3, Liang Yang4, Yong-Tang Zheng2, Yue-Mao Shen4, Zhi-Yu Li5, Xun Li4.   

Abstract

DNA topoisomerase II (topo II) is an important enzyme involved in DNA replication, recombination, and repair. Despite the popular applications of topo II inhibitors in cancer therapy, there is still an urgent need to upgrade topo II inhibitors to cope with drug resistance and severe adverse effects. Accordingly, novel topo II catalytic or multitarget topo II inhibitors are gaining more attention and make it possible to ease the toxic limitations of topo II poisons. In this review, medicinal chemistry approaches are mainly discussed toward the development of potent topo II inhibitors with low toxicities.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29870668     DOI: 10.1021/acs.jmedchem.7b01202

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  11 in total

1.  Design, Synthesis and Anti-Tumor Activity of Novel Benzimidazole-Chalcone Hybrids as Non-Intercalative Topoisomerase II Catalytic Inhibitors.

Authors:  Wei Zhou; Wenjin Zhang; Yi Peng; Zhi-Hong Jiang; Lanyue Zhang; Zhiyun Du
Journal:  Molecules       Date:  2020-07-12       Impact factor: 4.411

2.  Oncofetal HMGA2 attenuates genotoxic damage induced by topoisomerase II target compounds through the regulation of local DNA topology.

Authors:  Syed Moiz Ahmed; Peter Dröge
Journal:  Mol Oncol       Date:  2019-08-31       Impact factor: 6.603

3.  Smoothed Potential MD Simulations for Dissociation Kinetics of Etoposide To Unravel Isoform Specificity in Targeting Human Topoisomerase II.

Authors:  Jissy A Kuriappan; Neil Osheroff; Marco De Vivo
Journal:  J Chem Inf Model       Date:  2019-09-09       Impact factor: 4.956

4.  Etoposide Induces Mitochondrial Dysfunction and Cellular Senescence in Primary Cultured Rat Astrocytes.

Authors:  Minji Bang; Do Gyeong Kim; Edson Luck Gonzales; Kyoung Ja Kwon; Chan Young Shin
Journal:  Biomol Ther (Seoul)       Date:  2019-11-01       Impact factor: 4.634

5.  Novel, Potent, and Druglike Tetrahydroquinazoline Inhibitor That Is Highly Selective for Human Topoisomerase II α over β.

Authors:  Jose Antonio Ortega; Jose M Arencibia; Elirosa Minniti; Jo Ann W Byl; Sebastian Franco-Ulloa; Marco Borgogno; Vito Genna; Maria Summa; Sine Mandrup Bertozzi; Rosalia Bertorelli; Andrea Armirotti; Anna Minarini; Claudia Sissi; Neil Osheroff; Marco De Vivo
Journal:  J Med Chem       Date:  2020-10-20       Impact factor: 7.446

6.  A Unique Topoisomerase II Inhibitor with Dose-Affected Anticancer Mechanisms and Less Cardiotoxicity.

Authors:  Zhi-Ying Li; Guang-Sen Xu; Xun Li
Journal:  Cells       Date:  2021-11-12       Impact factor: 6.600

7.  Ciclopirox Olamine Exerts Tumor-Suppressor Effects via Topoisomerase II Alpha in Lung Adenocarcinoma.

Authors:  Jie Yin; Gang Che; Kan Jiang; Ziyang Zhou; Lingyun Wu; Mengyou Xu; Jian Liu; Senxiang Yan
Journal:  Front Oncol       Date:  2022-02-18       Impact factor: 6.244

8.  Substituted 4,5'-Bithiazoles as Catalytic Inhibitors of Human DNA Topoisomerase IIα.

Authors:  Kaja Bergant Loboda; Matej Janežič; Martina Štampar; Bojana Žegura; Metka Filipič; Andrej Perdih
Journal:  J Chem Inf Model       Date:  2020-06-22       Impact factor: 4.956

9.  Design and synthesis of thiadiazolo-carboxamide bridged β-carboline-indole hybrids: DNA intercalative topo-IIα inhibition with promising antiproliferative activity.

Authors:  Ramya Tokala; Sravani Sana; Uppu Jaya Lakshmi; Prasanthi Sankarana; Dilep Kumar Sigalapalli; Nikhil Gadewal; Jyoti Kode; Nagula Shankaraiah
Journal:  Bioorg Chem       Date:  2020-10-08       Impact factor: 5.275

10.  Dynophore-Based Approach in Virtual Screening: A Case of Human DNA Topoisomerase IIα.

Authors:  Matej Janežič; Katja Valjavec; Kaja Bergant Loboda; Barbara Herlah; Iza Ogris; Mirijam Kozorog; Marjetka Podobnik; Simona Golič Grdadolnik; Gerhard Wolber; Andrej Perdih
Journal:  Int J Mol Sci       Date:  2021-12-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.